AI-generated summary
The authors randomized 60 patients with stage II or III periodontitis to receive either photobiomodulation at 680 nm or local 1.2% atorvastatin gel, both alongside subgingival instrumentation. They report notable clinical improvements in both groups at 3 months, with greater probing depth reduction and attachment gain in the atorvastatin gel group. The authors conclude both approaches can be used as adjuncts, within the study's limitations.
- Participants
- 60
- Who or what was studied
- Patients with stage II or III periodontitis and pocket depths of 4 to 7 mm, aged 25 or older, excluding smokers, people with systemic conditions, and recent periodontal therapy or antibiotic use
- Wavelengths
- 680 nm
- Limits stated in the abstract
- The abstract notes results are limited to this study's constraints and provides no detail on follow-up beyond 3 months or on the size of the reported differences.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 680 nm
- Energy density (fluence)
- 6 J/cm2
- Power
- 0.1 W
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.